What type of study is this?

This is a Qualitative Study study.

November 8, 2025Open Access

Towards safer medication use in older adults: Investigating barriers and facilitators of deprescribing

MEMadhavi EerikeAll India Institute of Medical Sciences GRGomathi RamaswamyAll India Institute of Medical Sciences Raipur PRPriyadharsini RajendranJawaharlal Institute of Post Graduate Medical Education and Research

Key Points

Improving deprescribing practices enhances health outcomes for older adults in healthcare settings.
Identified barriers include limited healthcare access in rural areas and outdated knowledge of geriatric pharmacology.
Qualitative study involved in-depth interviews with physicians, affirming the need for structured guidelines.
Encourages interdisciplinary collaboration and digital tools like electronic health records to facilitate deprescribing.

Abstract

Aims Deprescribing, the process of stopping unnecessary medications, is essential for optimizing pharmacotherapy in older adults but is hindered by systemic, knowledge and patient‐related barriers. This study explored physicians' perspectives on barriers and facilitators to deprescribing in older adults using the Theoretical Domains Framework (TDF), in an LMIC setting with limited evidence. Methods A qualitative study was conducted using in‐depth interviews with physicians (n = 52) to explore barriers, facilitators and potential improvements in deprescribing practices. Thematic analysis was applied to identify key insights and patterns from the collected data. Results This study identified several barriers to deprescribing, including limited healthcare access in rural areas and knowledge gaps in geriatric pharmacology among resident doctors. Patient‐specific challenges, such as advanced age and multiple comorbidities, further complicated the process. The chronic use of medications like proton pump inhibitors (PPIs) and benzodiazepines was also a prominent barrier. Systemic and logistical issues, such as inefficient workflows and poor interdisciplinary coordination, were noted as critical impediments. Key facilitators included patient acceptance, which was pivotal for adherence and outcomes, and the active participation of educated patients in shared decision‐making processes. A growing acceptance of deprescribing among doctors, especially in government healthcare, was observed, with effective communication key to overcoming patient resistance and building trust. Conclusion Overcoming systemic barriers, enhancing patient education and implementing structured guidelines are key to improving deprescribing. Interdisciplinary collaboration and digital tools like electronic health records can further ensure safe medication discontinuation. Targeted interventions are essential to optimizing deprescribing and improving older adult's health outcomes.

Demander à l'IA

Bookmark

View Full Paper